Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Crocus and Cannabis Sa...
Routine Notice Added Final

USPTO Patent Granted for Crocus and Cannabis Sativa Composition

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent (US12582687B2) to ACTIV'INSIDE for a composition containing extracts of Crocus sativus and Cannabis sativa. The patent covers uses of this composition as a pharmaceutical product, food supplement, nutritional product, cosmetic product, or liquid for electronic cigarettes.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582687B2 to ACTIV'INSIDE for a novel composition. This composition comprises an extract of Crocus sativus containing safranal and an extract of Cannabis sativa containing cannabidiol (CBD). The patent covers various applications, including pharmaceutical products, food supplements, nutritional products, cosmetic products, and liquids for electronic cigarettes.

This patent grant is primarily informational for entities operating in the pharmaceutical, food, cosmetic, and vaping industries. While it does not impose new regulatory obligations, it signifies intellectual property protection for a specific composition. Companies involved in the development or marketing of similar products should be aware of this patent to avoid potential infringement issues. No immediate compliance actions are required, but legal counsel should be consulted for specific product development strategies.

Source document (simplified)

← USPTO Patent Grants

Composition based on Crocus sativus and Cannabis sativa

Grant US12582687B2 Kind: B2 Mar 24, 2026

Assignee

ACTIV'INSIDE

Inventors

David Gaudout, Stéphane Rey, Benoit Lemaire, Séverine Dubreuil, Benjamin Moras, Mégane Bornerie, Julien Stanisiere, Astrid Devulpillieres

Abstract

The present invention relates to a composition comprising (i) an extract of Crocus sativus comprising at least safranal, and (ii) an extract of Cannabis sativa comprising cannabidiol (CBD) and uses thereof as a pharmaceutical product, a food supplement, a nutritional product, a cosmetic product, or a liquid suitable for electronic cigarettes.

CPC Classifications

A61K 36/3482

Filing Date

2022-08-04

Application No.

18294676

Claims

17

View original document →

Named provisions

Composition based on Crocus sativus and Cannabis sativa

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582687B2

Who this affects

Applies to
Drug manufacturers Food manufacturers Cosmetic product manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3114 Food & Beverage Manufacturing 3345 Medical Device Manufacturing
Activity scope
Product Development Intellectual Property Management
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Food Safety Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.